Pulmonary Alveolar Proteinosis (PAP) is a rare disease characterised by the buildup of protein in the alveoli (air sacs) of the lungs, making breathing difficult. Although there is no definitive cure for the condition, several treatments are available to help manage its symptoms effectively.
Therapy is needed for the more severe cases where the condition does not improve on its own. However, the exact treatment differs based on the exact type and severity of the condition of PAP. Here are a few of the more common therapies and treatments for PAP for affected individuals:
| Type of Procedure | Estimated Costs in India |
| Bronchodilators | Rs. 135 - Rs. 600 |
| Lung Transplantation | Rs. 25,00,000 - Rs. 45,00,000 |
| Oxygen Therapy | Rs. 300 – Rs. 1,500 per hour |
Pulmonary Alveolar Proteinosis is a very rare condition with a global prevalence estimated at 7–10 cases per million people and in diverse clinical forms. Amongst all of the different clinical forms, Autoimmune PAP is the most common, affecting almost 90% of individuals who are affected with PAP.
The healthcare provider first conducts a medical assessment of the lungs if they suspect that you have PAP. Then ask questions related to lifestyle conditions and family medical history. Here are a few tests that determine the condition of PAP in individuals:
PAP occurs primarily due to autoimmune factors. However, there is also a prevalence of hereditary PAP in children. Hereditary PAP happens due to mutations in the CSF2RA or CSF2RB genes.
Most PAP patients have excellent long‑term survival, with 5‑year survival rates exceeding 90% when appropriately treated. Many patients live normal lifespans. However, if the patient has a mild case of PAP, there are more chances of being cured of the disease to an extent, with minor breathing problems later on in life.
If you have this condition, then it is important to seek prompt medical attention. A timely medical intervention can help prevent PAP from spiralling out of control and cause adverse effects.